Abstract
In Duchenne Muscular Dystrophy (DMD) and in the mdx mice, model of DMD, lack of dystrophin leads to skeletal and cardiac muscle loss, fibrosis and progressive cardiorespiratory failure. Biomarkers for DMD have been widely investigated to follow up the evolution of the disease, facing the new pharmacological, genetics and cellular therapies to DMD. In the present study, by using metabolomi…